An observational study in Cesarean Delivery, sponsored by Bagcilar Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Bagcilar Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This prospective observational cohort study will evaluate maternal and fetal blood gas parameters in women undergoing cesarean delivery under spinal or general anesthesia. Maternal venous blood samples will be obtained immediately before anesthesia induction, and umbilical arterial blood samples will be obtained after delivery and cord clamping. Blood gas parameters, including pH, pCO2, pO2, bicarbonate, base excess, lactate, and fetal carboxyhemoglobin levels, will be compared between the spinal and general anesthesia groups. The study will also evaluate maternal-fetal blood gas gradients, Apgar scores, neonatal intensive care requirements, and the relationship between smoking exposure and fetal carboxyhemoglobin levels.
Bagcilar Training and Research Hospital is the lead sponsor of 56 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pregnant women undergoing cesarean delivery at the Obstetrics and Gynecology Clinic of Bagcilar Training and Research Hospital. The study is a prospective observational cohort comparing maternal and fetal blood gas parameters and fetal carboxyhemoglobin levels according to the observed anesthesia technique (spinal or general anesthesia).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants undergoing cesarean delivery who receive spinal anesthesia as the anesthesia technique.
Other: Anesthesia Technique
Participants undergoing cesarean delivery who receive general anesthesia as the anesthesia technique.
Other: Anesthesia Technique
Observed anesthesia technique in women undergoing cesarean delivery. Participants received either spinal anesthesia or general anesthesia as part of routine clinical care; the anesthesia technique was not assigned by the study.
Umbilical artery pH
Umbilical arterial pH measured after delivery and cord clamping.
Time frame: Immediately after delivery
Maternal venous pH
Maternal venous pH measured immediately before anesthesia induction.
Time frame: Immediately before anesthesia induction
Umbilical artery pCO2
Umbilical arterial pCO2 measured after delivery and cord clamping.
Time frame: Immediately after delivery
Umbilical artery pO2
Umbilical arterial pO2 measured after delivery and cord clamping.
Time frame: Immediately after delivery
Maternal venous pCO2
Maternal venous pCO2 measured immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Maternal venous pO2
Maternal venous pO2 measured immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Umbilical artery HCO3
Umbilical arterial bicarbonate measured after delivery and cord clamping.
Time frame: Immediately after delivery
Maternal venous HCO3
Maternal venous bicarbonate measured immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Umbilical artery BE
Umbilical arterial base excess measured after delivery and cord clamping
Time frame: Immediately after delivery
Maternal venous BE
Maternal venous base excess measured immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Umbilical artery lactate
Umbilical arterial lactate measured after delivery and cord clamping
Time frame: Immediately after delivery
Maternal venous lactate
Maternal venous lactate measured immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Umbilical artery FCOHb
Fetal carboxyhemoglobin measured in umbilical arterial blood after delivery and cord clamping
Time frame: Immediately after delivery
Maternal venous FCOHb
Maternal carboxyhemoglobin measured in venous blood immediately before anesthesia induction
Time frame: Immediately before anesthesia induction
Maternal-fetal pH gradient (ΔpH)
Difference between maternal venous pH and umbilical arterial pH
Time frame: Immediately after delivery
Maternal-fetal pCO2 gradient (ΔpCO2)
Difference between maternal venous pCO2 and umbilical arterial pCO2
Time frame: Immediately after delivery
Maternal-fetal lactate gradient (Δlactate)
Difference between maternal venous lactate and umbilical arterial lactate
Time frame: Immediately after delivery
Apgar score at 1 minute
Apgar score assessed 1 minute after birth using the Apgar score (range, 0-10), with higher scores indicating better neonatal condition.
Time frame: 1 minute after birth
Apgar score at 5 minutes
Apgar score assessed 5 minutes after birth using the Apgar score (range, 0-10), with higher scores indicating better neonatal condition.
Time frame: 5 minutes after birth
Neonatal intensive care unit admission
Requirement for admission to the neonatal intensive care unit after birth
Time frame: During the immediate neonatal period
Neonatal intubation
Requirement for endotracheal intubation after birth
Time frame: During the immediate neonatal period
Maternal hypotension requiring treatment
Occurrence of maternal hypotension requiring pharmacologic treatment during cesarean delivery
Time frame: From anesthesia induction until the end of surgery
Maternal vasopressor requirement
Requirement for vasopressor administration for management of maternal hypotension during cesarean delivery
Time frame: From anesthesia induction until the end of surgery
Smoking exposure and fetal FCOHb
Association between maternal smoking exposure status and fetal carboxyhemoglobin level measured in umbilical arterial blood
Time frame: Immediately after delivery
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bagcilar Training and Research Hospital